GO:0032395 MHC class II receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032395 MHC class II receptor activity is a molecular function defined as combining with an MHC class II protein complex and transmitting a signal across the membrane to initiate a change in cell activity.
• The term includes T cell receptor activity (alpha-beta and gamma-delta) and is central to CD4+ T cell recognition of peptide-MHC class II complexes.
• MHC class II receptor activity is not limited to T cells; it is also used by other cell types, including gastric epithelial cells, where it can trigger apoptosis.
• Dysregulated MHC class II receptor signaling contributes to autoimmunity, cancer immune evasion, and neurodegenerative conditions such as stroke.
• Partial MHC class II constructs can modulate this activity and are being developed as immunomodulatory therapies for stroke.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models are essential to dissect the causal roles of MHC class II receptor components.
Description
MHC class II receptor activity (GO:0032395) is a molecular function that enables a cell to bind an MHC class II protein complex and convert that binding event into an intracellular signal, thereby changing cell behavior. This activity is best known as the T cell receptor (TCR) function of CD4+ T cells, but it also encompasses alpha-beta and gamma-delta TCR activities and is used by other cell types to sense their environment. The importance of this term lies in its central role in adaptive immunity: it is the molecular interface through which CD4+ T cells recognize processed exogenous antigens presented on MHC class II molecules. Beyond classical immunity, MHC class II receptor activity has been implicated in tumor immune evasion, where epigenetic silencing of MHC class II in tumor-associated macrophages alters immune surveillance. It also contributes to non-immune pathologies, such as Helicobacter pylori-induced gastric epithelial apoptosis, where MHC class II acts as a receptor. Researchers studying infection, autoimmunity, cancer, and neurodegeneration therefore need robust tools to manipulate and measure this activity.
MHC class II receptor activity At A Glance
| GO ID | GO:0032395 |
|---|---|
| GO term | MHC class II receptor activity |
| Ontology | molecular_function |
| Synonym | alpha-beta T cell receptor activity; gamma-delta T cell receptor activity; T cell receptor activity |
| Definition | Combining with an MHC class II protein complex and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. |
| Major function | Recognition of peptide-MHC class II complexes and initiation of intracellular signaling. |
| Related cellular component | Plasma membrane; T cell receptor complex. |
| Related biological process | T cell activation; adaptive immune response. |
What Is GO:0032395?
According to the Gene Ontology, MHC class II receptor activity (GO:0032395) is the molecular function of combining with an MHC class II protein complex and transmitting a signal from one side of the membrane to the other to initiate a change in cell activity. In practice, this means a receptor on the cell surface binds to a peptide-loaded MHC class II molecule and triggers downstream signaling. The term includes synonyms such as alpha-beta T cell receptor activity, gamma-delta T cell receptor activity, and T cell receptor activity, reflecting the fact that the T cell receptor is the canonical example of this function.
Why Is MHC class II receptor activity Important in Cell Biology?
MHC class II receptor activity is a cornerstone of adaptive immunity because it allows CD4+ T cells to detect foreign or altered self-peptides presented by MHC class II molecules. This function is essential for mounting effective responses against pathogens and for maintaining tolerance. When this activity is dysregulated, it can lead to autoimmune diseases, impaired tumor surveillance, and chronic inflammatory conditions. Moreover, non-immune cells can exploit MHC class II receptor activity to trigger apoptosis or other responses, as seen in H. pylori infection of gastric epithelial cells. Understanding the molecular details of this activity is therefore critical for developing targeted immunotherapies and for interpreting disease-associated genetic variants.
• Central to CD4+ T cell activation and adaptive immunity.
• Mediates recognition of peptide-MHC class II complexes by alpha-beta and gamma-delta T cell receptors.
• Involved in tumor immune evasion through epigenetic silencing of MHC class II in tumor-associated macrophages.
• Contributes to gastric epithelial apoptosis during H. pylori infection.
• Targeted by partial MHC class II constructs for immunomodulation in stroke.
• Dysregulation is linked to autoimmune and inflammatory diseases.
• Provides a molecular target for therapeutic intervention in cancer and neurodegeneration.
• Essential for vaccine-induced immunity and immune checkpoint blockade responses.
• Used as a model system to study receptor signaling and membrane-proximal events.
• Enables researchers to dissect antigen presentation and T cell repertoire selection.
What Happens During MHC class II receptor activity?
Ligand binding and receptor engagement
In simple terms: The receptor grabs onto a peptide-loaded MHC class II molecule.
The first step in MHC class II receptor activity is the direct binding of the receptor (typically a T cell receptor) to an MHC class II protein complex displaying a peptide. This interaction is highly specific and involves multiple contact points between the receptor's complementarity-determining regions and the MHC class II alpha-helices plus the bound peptide. Recognition can be influenced by the chemical nature of the peptide, including the presence of non-natural amino acids such as beta-amino acids.
Signal transmission across the membrane
In simple terms: Binding causes a change that sends a signal inside the cell.
Upon ligand engagement, the receptor undergoes conformational changes that are transmitted across the plasma membrane. This transmission is mediated by associated signaling subunits (e.g., CD3 chains) that contain immunoreceptor tyrosine-based activation motifs (ITAMs). The exact molecular details of how binding energy is converted into a biochemical signal are still an active area of research, but it is clear that the process initiates a cascade of intracellular phosphorylation events.
Initiation of intracellular signaling cascades
In simple terms: The signal triggers a chain reaction of proteins inside the cell.
The transmitted signal activates proximal tyrosine kinases, leading to phosphorylation of downstream adaptors and enzymes. This results in the activation of transcription factors such as NF-kB and NFAT, which drive changes in gene expression. The outcome can vary from cell proliferation and cytokine production to apoptosis, depending on the cell type and context.
Cellular responses and functional outcomes
In simple terms: The cell changes its behavior, such as dividing or dying.
The ultimate result of MHC class II receptor activity is a change in cell activity. In CD4+ T cells, this typically means activation, proliferation, and effector function. In other cells, such as gastric epithelial cells, it can trigger apoptosis. In tumor-associated macrophages, epigenetic control of MHC class II expression can modulate this activity and affect immune surveillance.
Key Genes Involved in GO:0032395 MHC class II receptor activity
The following genes encode the major protein components and regulators of MHC class II receptor activity.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HLA-DRA | MHC class II alpha chain | Forms the peptide-binding groove; target for knockout to abolish receptor activity. |
| HLA-DRB1 | MHC class II beta chain | Polymorphic; key for peptide presentation and T cell recognition. |
| CD4 | Co-receptor for MHC class II | Binds MHC class II and enhances T cell receptor signaling. |
| CD3E | T cell receptor signaling subunit | Contains ITAMs; essential for signal transduction. |
| CD3D | T cell receptor signaling subunit | Part of the CD3 complex; required for surface expression. |
| CD3G | T cell receptor signaling subunit | Modulates receptor assembly and signaling. |
| CD3Z (CD247) | T cell receptor zeta chain | Major ITAM-bearing subunit; critical for signaling. |
| TRAC | T cell receptor alpha constant | Knockout abolishes alpha-beta TCR surface expression. |
| TRBC1 | T cell receptor beta constant 1 | Required for alpha-beta TCR function. |
| TRBC2 | T cell receptor beta constant 2 | Alternative beta constant region. |
| TRDC | T cell receptor delta constant | Gamma-delta TCR component. |
| TRGC1 | T cell receptor gamma constant 1 | Gamma-delta TCR component. |
| CIITA | Master transcription factor for MHC class II | Regulates MHC class II gene expression; knockout reduces receptor activity. |
| RFX5 | MHC class II transcription factor | Part of the enhanceosome; mutations cause bare lymphocyte syndrome. |
| RFXAP | MHC class II transcription factor | Required for CIITA-mediated activation. |
| RFXANK | MHC class II transcription factor | Mutations impair MHC class II expression. |
| LAG3 | Inhibitory receptor binding MHC class II | Ligand for MHC class II; modulates T cell activity. |
How Is MHC class II receptor activity Regulated?
MHC class II receptor activity is regulated at multiple levels. Transcription of MHC class II genes is controlled by the master regulator CIITA and its associated transcription factors, which respond to interferon-gamma and other signals. Epigenetic mechanisms, such as histone acetylation and DNA methylation, also modulate MHC class II expression in tumor-associated macrophages. At the protein level, receptor activity can be tuned by the availability of peptide-MHC complexes, co-receptors like CD4, and inhibitory receptors such as LAG-3, which binds MHC class II and dampens T cell responses. Additionally, partial MHC class II constructs can act as decoys or modulators, altering downstream signaling.
MHC class II receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HLA-DRB1 | Autoimmune diseases (e.g., rheumatoid arthritis) | Knock-in of risk alleles in cell lines; KO in primary T cells. |
| CIITA | Bare lymphocyte syndrome | KO in B cells or macrophages; overexpression to boost MHC class II. |
| LAG3 | Cancer immune evasion | KO in T cells; overexpression in tumor models. |
| HLA-DRA | H. pylori-induced gastric apoptosis | KO in gastric epithelial cells; point mutations in peptide-binding groove. |
| CD4 | HIV infection and autoimmunity | Knock-in of human CD4 into mouse models; KO in T cells. |
Cancer immune evasion
MHC class II receptor activity is often dysregulated in cancer. Epigenetic silencing of MHC class II in tumor-associated macrophages reduces antigen presentation and impairs anti-tumor immunity. Restoring MHC class II expression or enhancing receptor activity could improve responses to immune checkpoint inhibitors. Additionally, inhibitory receptors like LAG-3, which binds MHC class II, contribute to T cell exhaustion in tumors.
Infectious and inflammatory diseases
Helicobacter pylori exploits MHC class II as a receptor on gastric epithelial cells to induce apoptosis, contributing to gastric pathology. This highlights how pathogens can hijack MHC class II receptor activity for their own benefit. In autoimmune diseases, aberrant MHC class II receptor signaling drives inappropriate T cell activation against self-antigens.
Neurodegeneration and stroke
Partial MHC class II constructs have shown promise as immunomodulatory therapy for stroke by altering MHC class II receptor activity and reducing neuroinflammation. This suggests that targeting this molecular function could be beneficial in acute and chronic neurodegenerative conditions.
From MHC class II receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of MHC class II receptor activity abolish T cell activation? | Knockout of HLA-DRA or CD3E in Jurkat or primary T cells. |
| How do point mutations in the peptide-binding groove affect ligand recognition? | Point mutation knock-in of HLA-DRB1 in antigen-presenting cells. |
| Can a tagged MHC class II receptor be used to track signaling? | Knock-in of fluorescent or epitope tags into HLA-DRA or CD3E. |
| Does overexpression of CIITA enhance antigen presentation? | Overexpression of CIITA in tumor cells or macrophages. |
| What is the effect of LAG-3 on MHC class II receptor activity? | Knockout or overexpression of LAG3 in T cells. |
| Can partial MHC class II constructs modulate signaling in stroke? | Knock-in of soluble MHC class II constructs in mouse models. |
How to Study the MHC class II receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Flow cytometry with tetramers | Antigen-specific T cell frequency and receptor binding | Monitoring immune responses. |
| CRISPR knockout screens | Genes required for MHC class II receptor activity | Discovery of novel regulators. |
| Immunoblotting | Phosphorylation of signaling proteins | Quantifying signal transduction. |
| Mass spectrometry | Protein interactions and post-translational modifications | Identifying receptor complex components. |
| Proximity ligation assay | In situ protein-protein interactions | Visualizing receptor clustering. |
| RNA-seq | Transcriptional changes upon receptor activation | Defining downstream gene expression programs. |
| ATAC-seq | Chromatin accessibility at MHC class II loci | Studying epigenetic regulation. |
| Surface plasmon resonance | Binding affinity between receptor and MHC class II | Characterizing ligand recognition. |
Flow cytometry and tetramer staining
Flow cytometry using peptide-MHC class II tetramers allows direct detection of receptor engagement and quantification of antigen-specific T cells. This method is essential for studying the specificity and avidity of MHC class II receptor activity.
CRISPR screening and functional genomics
Genome-wide CRISPR knockout screens can identify genes that regulate MHC class II receptor activity, such as those involved in antigen presentation or signaling. These screens are powerful for discovering novel modulators and potential drug targets.
Biochemical signaling assays
Phosphorylation of ITAMs and downstream kinases can be measured by immunoblotting or mass spectrometry after receptor engagement. These assays provide a quantitative readout of signal transmission.
Imaging and proximity ligation
Advanced imaging techniques, including total internal reflection fluorescence (TIRF) and proximity ligation assays, can visualize receptor clustering and membrane-proximal signaling events in real time.
How CRISPR Can Be Used to Study GO:0032395 MHC class II receptor activity
Knockout
CRISPR knockout of genes encoding MHC class II receptor components (e.g., HLA-DRA, CD3E) or regulators (e.g., CIITA) can completely abolish receptor activity, providing a clean background to study loss-of-function phenotypes. This approach is ideal for validating essentiality in T cell activation and antigen presentation.
Point Mutation
Point mutations can be introduced into the peptide-binding groove of MHC class II or the complementarity-determining regions of the T cell receptor to dissect specificity and affinity. Such models help determine how single amino acid changes affect ligand recognition and downstream signaling.
Knock-in
Knock-in of tagged or fluorescent versions of MHC class II or TCR subunits allows real-time tracking of receptor localization and signaling dynamics. Knock-in of disease-associated alleles (e.g., HLA-DRB1 risk variants) can model autoimmune susceptibility.
Overexpression
Overexpression of CIITA or MHC class II genes can enhance antigen presentation and boost receptor activity, which is useful for studying gain-of-function effects in cancer immune evasion or vaccine development.
How EDITGENE Supports MHC class II receptor activity Research
Researchers studying MHC class II receptor activity-related genes often need to determine whether a candidate gene is causally involved in receptor function, signaling, or downstream cellular responses. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional validation.
Contact EDITGENE today to design your custom CRISPR model for MHC class II receptor activity research.
Frequently Asked Questions About MHC class II receptor activity
What is MHC class II receptor activity?
MHC class II receptor activity (GO:0032395) is a molecular function where a receptor binds an MHC class II protein complex and transmits a signal across the membrane to change cell behavior.
What genes are involved in MHC class II receptor activity?
Key genes include HLA-DRA, HLA-DRB1, CD4, CD3E, CD3D, CD3G, CD247, TRAC, TRBC1, TRBC2, CIITA, and RFX5.
What diseases are associated with MHC class II receptor activity?
It is linked to autoimmune diseases, cancer immune evasion, H. pylori-induced gastric apoptosis, and stroke.
How is MHC class II receptor activity regulated?
It is regulated transcriptionally by CIITA and epigenetically by histone modifications; LAG-3 binding also modulates activity.
What are the synonyms for GO:0032395?
Synonyms include alpha-beta T cell receptor activity, gamma-delta T cell receptor activity, and T cell receptor activity.
Which cell types use MHC class II receptor activity?
It is primarily used by CD4+ T cells, but also by gamma-delta T cells and non-immune cells such as gastric epithelial cells.
How can I study MHC class II receptor activity in the lab?
Common methods include flow cytometry with tetramers, CRISPR screens, immunoblotting, and imaging techniques.
What CRISPR models are available for MHC class II receptor activity?
Knockout, point mutation, knock-in, and overexpression models can be generated for genes like HLA-DRA, CIITA, and CD3E.
Why is MHC class II receptor activity important for cancer?
Epigenetic silencing of MHC class II in tumor-associated macrophages impairs anti-tumor immunity, making this activity a target for immunotherapy.
Can MHC class II receptor activity be targeted therapeutically?
Yes, partial MHC class II constructs are being developed as immunomodulatory therapy for stroke, and LAG-3 blockade enhances T cell responses.
Conclusion
MHC class II receptor activity (GO:0032395) is a fundamental molecular function that bridges innate and adaptive immunity by enabling cells to recognize peptide-MHC class II complexes and translate that recognition into functional responses. Its dysregulation contributes to cancer, autoimmunity, infection, and neurodegeneration, making it a high-value target for basic and translational research. Advances in CRISPR-based genome editing now allow precise manipulation of the genes underlying this activity, accelerating the discovery of new therapeutic strategies.
References
- 1. Wang J et al.. 2019. Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3.. Cell 176(1-2):334-347.e12 PMID: 30580966
- 4. van den Elsen PJ et al.. 1998. Regulation of MHC class I and II gene transcription: differences and similarities.. Immunogenetics 48(3):208-21 PMID: 9683666
- 5. Chang YC et al.. 2008. Epigenetic control of MHC class II expression in tumor-associated macrophages by decoy receptor 3.. Blood 111(10):5054-63 PMID: 18349319
- 6. Cheloha RW et al.. 2019. Recognition of Class II MHC Peptide Ligands That Contain β-Amino Acids.. J Immunol 203(6):1619-1628 PMID: 31391235
- 7. Bland DA et al.. 2006. H. pylori receptor MHC class II contributes to the dynamic gastric epithelial apoptotic response.. World J Gastroenterol 12(33):5306-10 PMID: 16981259
- 8. Benedek G et al.. 2017. Partial MHC class II constructs as novel immunomodulatory therapy for stroke.. Neurochem Int 107:138-147 PMID: 27773790
